Sangamo Biosciences, Inc. (NASDAQ: SGMO) reported Q1 EPS of ($0.12), $0.01 better than the analyst estimate of ($0.13). Revenue for the quarter came in at $8.1 million versus the consensus estimate of $6.59 million.

For earnings history and earnings-related data on Sangamo Biosciences, Inc. (SGMO) click here.